Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ADMA Biologics Inc (ADMA) vs First Citizens BancShares Inc (FCNCA) Price & Performance

ADMA Biologics IncTrade
First Citizens BancShares IncTrade

Price performance (Past 24H)

Key statistics

ADMA Biologics Inc vs First Citizens BancShares Inc — how do they compare? ADMA Biologics Inc trades at $9.35 (market cap $2.19B), while First Citizens BancShares Inc trades at $2,270.44 (market cap $25.26B). The key difference: First Citizens BancShares Inc is far larger — about 11.5× ADMA Biologics Inc's market cap, and First Citizens BancShares Inc pays a 0.37% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.

ADMAFCNCA
Market Cap
$2.19B$25.26B
Sector
HealthSector/Thematic
52-Week High
$20.38$2.27K
52-Week Low
$7.60$1.64K
Enterprise Value
$2.26B
Dividend Yield
0.37%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.

Read more on ADMA

About First Citizens BancShares Inc

First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.

Read more on FCNCA